Fifth Third Bancorp’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $444K | Sell |
2,347
-85
| -3% | -$14.9K | ﹤0.01% | 2098 |
|
|
2025
Q4 | $413K | Buy |
2,432
+30
| +1% | +$4.6K | ﹤0.01% | 830 |
|
|
2025
Q3 | $317K | Sell |
2,402
-269
| -10% | -$32.3K | ﹤0.01% | 934 |
|
|
2025
Q2 | $283K | Sell |
2,671
-946
| -26% | -$103K | ﹤0.01% | 895 |
|
|
2025
Q1 | $449K | Buy |
3,617
+3,201
| +769% | +$418K | ﹤0.01% | 770 |
|
|
2024
Q4 | $51.2K | Sell |
416
-30
| -7% | -$3.54K | ﹤0.01% | 1380 |
|
|
2024
Q3 | $49.7K | Sell |
446
-3,241
| -88% | -$355K | ﹤0.01% | 1431 |
|
|
2024
Q2 | $394K | Sell |
3,687
-2,176
| -37% | -$239K | ﹤0.01% | 818 |
|
|
2024
Q1 | $706K | Buy |
5,863
+752
| +15% | +$92.1K | ﹤0.01% | 678 |
|
|
2023
Q4 | $629K | Sell |
5,111
-228
| -4% | -$28.5K | ﹤0.01% | 692 |
|
|
2023
Q3 | $691K | Buy |
5,339
+114
| +2% | +$15.2K | ﹤0.01% | 647 |
|
|
2023
Q2 | $648K | Sell |
5,225
-1,940
| -27% | -$261K | ﹤0.01% | 663 |
|
|
2023
Q1 | $1.05M | Buy |
7,165
+3,112
| +77% | +$460K | ﹤0.01% | 559 |
|
|
2022
Q4 | $646K | Sell |
4,053
-1,042
| -20% | -$153K | ﹤0.01% | 636 |
|
|
2022
Q3 | $679K | Buy |
5,095
+4,816
| +1,726% | +$732K | ﹤0.01% | 626 |
|
|
2022
Q2 | $44K | Buy |
279
+69
| +33% | +$10.6K | ﹤0.01% | 1414 |
|
|
2022
Q1 | $33K | Buy |
210
+56
| +36% | +$8.13K | ﹤0.01% | 1620 |
|
|
2021
Q4 | $20K | Buy |
154
+37
| +32% | +$4.86K | ﹤0.01% | 1856 |
|
|
2021
Q3 | $15K | Buy |
117
+70
| +149% | +$10.6K | ﹤0.01% | 1876 |
|
|
2021
Q2 | $8K | Buy |
47
+27
| +135% | +$4.68K | ﹤0.01% | 2077 |
|
|
2021
Q1 | $3K | Buy |
20
+15
| +300% | +$2.47K | ﹤0.01% | 2267 |
|
|
2020
Q4 | $1K | Buy |
+5
| New | +$745 | ﹤0.01% | 2292 |
|
|
2020
Q3 | – | Sell |
-24
| Closed | -$3K | – | 2321 |
|
|
2020
Q2 | $3K | Sell |
24
-56
| -70% | -$6.19K | ﹤0.01% | 1935 |
|
|
2020
Q1 | $8K | Hold |
80
| – | – | ﹤0.01% | 1780 |
|
|
2019
Q4 | $12K | Buy |
80
+23
| +40% | +$3.13K | ﹤0.01% | 1802 |
|
|
2019
Q3 | $7K | Buy |
57
+6
| +12% | +$804 | ﹤0.01% | 1881 |
|
|
2019
Q2 | $7K | Buy |
51
+24
| +89% | +$3.23K | ﹤0.01% | 1930 |
|
|
2019
Q1 | $4K | Buy |
27
+25
| +1,250% | +$3.26K | ﹤0.01% | 1974 |
|
|
2018
Q4 | $0 | Buy |
+2
| New | +$297 | ﹤0.01% | 2288 |
|
|
2018
Q2 | – | Sell |
-24
| Closed | -$4K | – | 2317 |
|
|
2018
Q1 | $4K | Sell |
24
-216
| -90% | -$31.7K | ﹤0.01% | 2094 |
|
|
2017
Q4 | $32K | Buy |
240
+45
| +23% | +$6.24K | ﹤0.01% | 1431 |
|
|
2017
Q3 | $29K | Sell |
195
-105
| -35% | -$15.9K | ﹤0.01% | 1478 |
|
|
2017
Q2 | $47K | Sell |
300
-50
| -14% | -$7.65K | ﹤0.01% | 1297 |
|
|
2017
Q1 | $51K | Buy |
350
+14
| +4% | +$1.82K | ﹤0.01% | 1290 |
|
|
2016
Q4 | $37K | Sell |
336
-4,018
| -92% | -$448K | ﹤0.01% | 1436 |
|
|
2016
Q3 | $529K | Sell |
4,354
-971
| -18% | -$131K | ﹤0.01% | 716 |
|
|
2016
Q2 | $752K | Sell |
5,325
-251
| -5% | -$37K | 0.01% | 601 |
|
|
2016
Q1 | $728K | Buy |
5,576
+208
| +4% | +$25.9K | 0.01% | 612 |
|
|
2015
Q4 | $755K | Sell |
5,368
-1,567
| -23% | -$217K | 0.01% | 609 |
|
|
2015
Q3 | $921K | Buy |
6,935
+940
| +16% | +$162K | 0.01% | 564 |
|
|
2015
Q2 | $1.06M | Buy |
5,995
+914
| +18% | +$164K | 0.01% | 568 |
|
|
2015
Q1 | $878K | Buy |
5,081
+500
| +11% | +$85.8K | 0.01% | 611 |
|
|
2014
Q4 | $750K | Sell |
4,581
-73
| -2% | -$12.1K | 0.01% | 637 |
|
|
2014
Q3 | $747K | Buy |
4,654
+4,482
| +2,606% | +$689K | 0.01% | 630 |
|
|
2014
Q2 | $25K | Sell |
172
-8
| -4% | -$1.11K | ﹤0.01% | 1725 |
|
|
2014
Q1 | $25K | Buy |
+180
| New | +$27.1K | ﹤0.01% | 1700 |
|
Other funds holding JAZZ
VPM
VCM
EC
Fifth Third Bancorp's JAZZ Position: Q1 2026 in Review
Fifth Third Bancorp reduced its Jazz Pharmaceuticals (JAZZ) stake by 3.5% in Q1 2026, selling an estimated $14.9K and leaving 2,347 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #2098.
Fifth Third Bancorp first reported a position in JAZZ in Q1 2014 and has held it in 46 quarters since. The position peaked at $1.06M in Q2 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Fifth Third Bancorp held 2,347 shares of Jazz Pharmaceuticals worth $444K as of Q1 2026.
- Fifth Third Bancorp sold 85 Jazz Pharmaceuticals shares in Q1 2026, an estimated $14.9K.
- Jazz Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2098 holding.
- Fifth Third Bancorp first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 46 quarters since.
- Fifth Third Bancorp's Jazz Pharmaceuticals position peaked at $1.06M in Q2 2015.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.